T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alcon
ALC
|
+$2.11B |
| 2 |
Linde
LIN
|
+$1.34B |
| 3 |
American International
AIG
|
+$1.34B |
| 4 |
Marvell Technology
MRVL
|
+$1.28B |
| 5 |
TSS
Total System Services, Inc.
TSS
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$2.27B |
| 2 |
Eli Lilly
LLY
|
+$1.64B |
| 3 |
NVIDIA
NVDA
|
+$1.59B |
| 4 |
RHT
Red Hat Inc
RHT
|
+$1.55B |
| 5 |
Booking.com
BKNG
|
+$1.12B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.92% |
| 2 | Healthcare | 17.37% |
| 3 | Financials | 13.84% |
| 4 | Consumer Discretionary | 13.63% |
| 5 | Industrials | 9.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1401
Dell
DELL
$320B
| $4.64M | ﹤0.01% |
180,180
+27,355
| +18% | +$853K |
|
1402
Lumentum
LITE
$78B
| $4.64M | ﹤0.01% |
86,808
+280
| +0.3% | +$14.9K |
|
1403
Oceaneering
OII
$5.08B
| $4.63M | ﹤0.01% |
227,184
-899,342
| -80% | -$15.9M |
|
|
ITCI
1404
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $4.61M | ﹤0.01% |
355,500
-563
| -0.2% | -$7.22K |
|
1405
Reinsurance Group of America
RGA
$16.1B
| $4.61M | ﹤0.01% |
29,543
+111
| +0.4% | +$16.6K |
|
1406
Yext
YEXT
$613M
| $4.6M | ﹤0.01% |
228,757
+385
| +0.2% | +$7.93K |
|
|
SJI
1407
DELISTED
South Jersey Industries, Inc.
SJI
| $4.57M | ﹤0.01% |
135,573
+226
| +0.2% | +$7.3K |
|
1408
AGNC Investment
AGNC
$13B
| $4.51M | ﹤0.01% |
268,211
+202
| +0.1% | +$3.51K |
|
1409
Trimble
TRMB
$13.4B
| $4.38M | ﹤0.01% |
97,208
+96
| +0.1% | +$3.99K |
|
1410
iShares Core MSCI EAFE ETF
IEFA
$196B
| $4.34M | ﹤0.01% |
70,763
+10,625
| +18% | +$651K |
|
1411
Oshkosh
OSK
$9.41B
| $4.27M | ﹤0.01% |
51,102
+122
| +0.2% | +$9.6K |
|
|
TCO
1412
DELISTED
Taubman Centers Inc.
TCO
| $4.21M | ﹤0.01% |
103,218
+9,417
| +10% | +$453K |
|
1413
Bio-Techne
TECH
$11.2B
| $4.2M | ﹤0.01% |
80,644
+2,316
| +3% | +$117K |
|
|
ASRT
1414
DELISTED
Assertio
ASRT
| $4.2M | ﹤0.01% |
20,292
+4
| +0% | +$952 |
|
1415
Carlisle Companies
CSL
$15.2B
| $4.11M | ﹤0.01% |
29,295
+1,175
| +4% | +$158K |
|
1416
Invitation Homes
INVH
$17.7B
| $4.08M | ﹤0.01% |
152,622
+1,214
| +0.8% | +$30.9K |
|
1417
Vipshop
VIPS
$6.94B
| $4.01M | ﹤0.01% |
465,043
+411,643
| +771% | +$3.32M |
|
1418
Star Group
SGU
$417M
| $4.01M | ﹤0.01% |
401,325
| – | – |
|
1419
Howard Hughes
HHH
$4.04B
| $4M | ﹤0.01% |
33,871
+31
| +0.1% | +$3.18K |
|
|
DESP
1420
DELISTED
Despegar.com
DESP
| $3.98M | ﹤0.01% |
286,262
+47,500
| +20% | +$649K |
|
1421
Gentex
GNTX
$4.93B
| $3.95M | ﹤0.01% |
160,663
-40
| -0% | -$906 |
|
1422
Kinsale Capital Group
KNSL
$8.59B
| $3.95M | ﹤0.01% |
43,198
-31,623
| -42% | -$2.53M |
|
1423
SEI Investments
SEIC
$12.7B
| $3.94M | ﹤0.01% |
70,182
-11,875
| -14% | -$640K |
|
|
PE
1424
DELISTED
PARSLEY ENERGY INC
PE
| $3.94M | ﹤0.01% |
207,118
-2,716
| -1% | -$51.9K |
|
1425
Graphic Packaging
GPK
$3.51B
| $3.92M | ﹤0.01% |
280,512
-793,576
| -74% | -$10.6M |
|
Similar funds
T. Rowe Price Associates's Q2 2019 Portfolio in Review
As of Q2 2019, T. Rowe Price Associates held 2,600 positions worth $712B, up 4.7% from $680B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
T. Rowe Price Associates's Q2 2019 filing shows 72 new, 1,394 increased, 949 reduced and 59 closed positions. Its largest new stake was Alcon: 36,020,796 shares worth $2.23B. The largest sale was UnitedHealth, an estimated $2.27B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2019 buy was Alcon: 36,020,796 shares worth $2.23B.
- T. Rowe Price Associates added most to Linde in Q2 2019, an estimated $1.34B increase.
- T. Rowe Price Associates's biggest Q2 2019 reduction was UnitedHealth, cutting an estimated $2.27B.
- T. Rowe Price Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $609M.
- T. Rowe Price Associates's ten largest holdings make up 21% of its $712B portfolio in Q2 2019.
- T. Rowe Price Associates opened 72 new positions and closed 59 in Q2 2019.
- T. Rowe Price Associates's portfolio value rose 4.7% quarter-over-quarter to $712B.
Based on T. Rowe Price Associates's 13F filing for Q2 2019, filed 15 Aug 2019.